BioLife Solutions (BLFS) is a stock to benefit from the early innings of regenerative medicine revolution with multiple avenues for growth ahead if it.
Not only does it continue to gain new customers involved in clinical trials, but this also increases the pool of customers which eventually receive regulatory approval after which they generate much more significant amounts of revenues.
Then, the company is already profitable and generating cash flow, which it uses for acquisitions, buying into complementary products which generate revenue and/or cost synergies.
BioLife is one of our favorite companies and